What is Barclays's price target for CFLT?

Barclays's latest stated price target for Confluent Inc. (CFLT) is $24, from its action on Jan 10, 2023.

What is Barclays's rating on CFLT?

Barclays rates CFLT Overweight, a bullish rating, as of Jan 10, 2023.

When did Barclays last change its view on CFLT?

On Jan 10, 2023, Barclays upgrades to Overweight from Equal Weight, price target $27 to $24.

Barclays CFLT price target and rating history

Barclays rates Confluent Inc. (CFLT) Overweight with a $24 price target, as of its latest action on Jan 10, 2023. It has published 4 rating actions on CFLT since July 2021, including 1 upgrade and 0 downgrades.

Current rating: Overweight
Price target: $24
Median target, all firms: Too few
Actions on CFLT: 4

Barclays price target on CFLT

Barclays price target on CFLT, each point a stated target, July 2021 to January 2023.

Every Barclays rating on CFLT

Jan 10, 2023
UpgradeBarclays upgrades to Overweight from Equal Weight, price target $27 to $24
Oct 18, 2021
ReiterateBarclays raises its price target to $68 from $62, keeps Equal-Weight
Aug 6, 2021
ReiterateBarclays raises its price target to $47 from $42, keeps Equal-Weight
Jul 19, 2021
InitiateBarclays starts coverage at Equal-Weight, price target $42

How other firms rate CFLT

Each firm's latest rating and stated target in the last 12 months.

Firm	Rating	Price target	Date
Bernstein	Mkt Perform	$31	Jan 23, 2026
Citizens JMP	Mkt Perform		Jan 9, 2026

Questions about Barclays and CFLT

What is Barclays's price target for CFLT?: Barclays's latest stated price target for Confluent Inc. (CFLT) is $24, from its action on Jan 10, 2023.
What is Barclays's rating on CFLT?: Barclays rates CFLT Overweight, a bullish rating, as of Jan 10, 2023.
When did Barclays last change its view on CFLT?: On Jan 10, 2023, Barclays upgrades to Overweight from Equal Weight, price target $27 to $24.

More CFLT rating histories

All Barclays ratings CFLT news and filings Every analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.